Schedule 13D ownership disclosure
REATA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75615P103
Event date: 2020-12-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-313455
- Form type
- SC 13D
- Filer
- REATA PHARMACEUTICALS INC
- CIK
- CIK 1358762
- Filed
- Dec 09, 2020
- Reporting period
- Dec 04, 2020
- Description
- Schedule 13D beneficial ownership